At Jazz Pharmaceuticals, our mission is to improve patients’ lives by identifying, developing and commercializing products including: XYREM, ERWINAZE, PRIALT, FAZACLO HD and LD and VERSACLOZ. The product information on XYREM, ERWINAZE, PRIALT, FAZACLO HD and LD and VERSACLOZ is intended only for residents of the United States. Click on the logos below to view complete prescribing information, including boxed warnings.

In addition to these products marketed in the U.S., EUSA Pharma, an international division of Jazz Pharmaceuticals, markets products outside of the U.S. in more than 80 countries. For more information please visit:

To report an adverse event or a product complaint, or to request information about our products, please click here.